心理用語集ver2.xlsx

untitled

1 4 2 3 4 2 3 OJT/offJT () 2

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

Microsoft Word - 講演録.docx

2015.9.7 70 21 11 3 22 5 3 14 1 1 1 2 3 2 2 12 7 3 6 1 7 11 2 3 4 1 1 3 11 (1) (2) (2) 5 2 ( ) 6 15 6 6 2 0 PTSD PTSD PTSD 5 50 7 240 17 3 31 560 PTSD 560 500 500 8 40 9 2 11 1 1 750 700 PTSD 350 10 1

10 1-1 - 30 2-2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - 18-9 - - 10 - PTSD 100-11 - - 12 - - 13 - 17 // - 14 - 27 151-15 - - 16 - - 17 - - 18 - - 19 - - 20 - E - 21 - - 22 - - 23 - - 24 - - 25 - 28 4-26

MultiWriter 5600C 活用マニュアル

1 *1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 9 1 2 3 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 2 3 a b c 26 27 28 C *1 *2 *2 29 2 2 2 2 2 2 2 2 2 30 *1 *2 ± *1 C C 31 32 33 34 35 36 M C Y K 1 2 3 4 5 6

ガス溶接器・切断器.PDF

untitled

13,000 1 35,400 8,000 1 35,400 2 ~6 46,000 2 ~6 46,000 7 55,000 7 55,200 2,750 2,750 4,910 4,910 149,000 149,000 45,000 75,000 45,000 75,000 189,000 165,400 151,200 132,300 33 29 4 33 29 4 150,410 128,100

Q1. A. Q2. A. 3 12 3 A IQ35 IQ50 20 20 2

2015電磁波＿歯科医.rtfd

untitled

20 7 1 22 7 1 1 2 3 7 8 9 10 11 13 14 15 17 18 19 21 22 - 1 - - 2 - - 3 - - 4 - 50 200 50 200-5 - 50 200 50 200 50 200 - 6 - - 7 - () - 8 - (XY) - 9 - 112-10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 -

untitled

19 1 19 19 3 8 1 19 1 61 2 479 1965 64 1237 148 1272 58 183 X 1 X 2 12 2 15 A B 5 18 B 29 X 1 12 10 31 A 1 58 Y B 14 1 25 3 31 1 5 5 15 Y B 1 232 Y B 1 4235 14 11 8 5350 2409 X 1 15 10 10 B Y Y 2 X 1 X

DSP工法.pdf

広報うちなだ2002年6月号

1 2

1 2 4 3 5 6 8 7 9 10 12 11 0120-889-376 r 14 13 16 15 0120-0889-24 17 18 19 0120-8740-16 20 22 21 24 23 26 25 28 27 30 29 32 31 34 33 36 35 38 37 40 39 42 41 44 43 46 45 48 47 50 49 52 51 54 53 56 55 58

平成28年度第1回高等学校卒業程度認定試験問題（科学と人間生活）

01-02.{.....o.E.N..

3 5 6 7 7 8 9 5 7 9 4 5 6 6 7 8 8 8 9 9 3 3 3 3 8 46 4 49 57 43 65 6 7 7 948 97 974 98 99 993 996 998 999 999 4 749 7 77 44 77 55 3 36 5 5 4 48 7 a s d f g h a s d f g h a s d f g h a s d f g h j 83 83

13

/41

3 1 3 2 7 2-1 7 3 8 3-1 7S 8 3-2 9 3-2-1 9 3-2-2 10 3-2-3 10 3-2-4 10 3-2-5 11 3-2-6 11 3-2-7 12 4 13 4-1 13 4-2 13 4-2-1 13 4-2-2 13 4-3 14 4-3-1 5 14 4-3-2 XY 15 4-3-3 16 4-4 17 4-4-1 17 4-4-2 & 17 4-4-3

福沢論文

*p145-174_Œâ‡í‡ê‡é

*p145-174_ 問 われる 09.1.16 10:34 PM ページ145 2007 200708 146 147 a s 148 a s d f g 153 a s d 158 a s d f g h j 166 a s d f 171 2009 145 *p145-174_ 問 われる 09.1.16 10:34 PM ページ146 45 2007 2008 146 *p145-174_

2 of 46 07.2.10 4:30 PM

1 of 46 07.2.10 4:30 PM 2 of 46 07.2.10 4:30 PM 3 of 46 07.2.10 4:30 PM 4 of 46 07.2.10 4:30 PM 5 of 46 07.2.10 4:30 PM 6 of 46 07.2.10 4:30 PM 7 of 46 07.2.10 4:30 PM 8 of 46 07.2.10 4:30 PM 9 of 46 07.2.10

広報かわぐち 2005年2月号

研究紀要 第14号 (研究ﾉｰﾄ1)

untitled

p1

u u u 1 1

21 1 503604705 MRI CT 1 3 MRIMRS 5 5 5 5 5 6 7 8 17 1 17 2 17 3 17 4 18 5 19 21 1 23 2 1 27 3 2 48 4 3 88 5 105 6 110 7 118 MRS MRS ATP 312CT 65 60 1 2 1 1 1 2 1 2 2 X CT MRS 3 36657269 MRIMRS 1.5TMRSymphony

2

D 1 2 3 XX XY ( ) 4 5 GID ( ) ( ) ( ) ( ) WHO( ) ( ) ( ) WHO ( ) WHO ( ) 6 7 8 9 X Y XX XY XO XXY XXXY Y Y SRY Y SRY X XX XY SRY XY XX Y Y X Y Y DNA DNA 10 XY XY 11 12 13 F M T 14 U H R 15 K N F 16 M T

untitled

BMI BMI

() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3

-1-15 12 14 13 13 76. 22.7 9.8 2.3 13 0.1 1.6 21.1 43.5 32.6 0.1 9.7 47.6 36.7 15 10 32 12 21 13 12-2- -3-10 12 57 60 12 11 12 13 10 14 10 20 -4-13 36.6 15 12 13, 102 277 150 . 3033 31 58 38 56 45 60 31

x : = : x x

x : = : x x x :1 = 1: x 1 x : = : x x : = : x x : = : x x ( x ) = x = x x = + x x = + + x x = + + + + x = + + + + +L x x :1 = 1: x 1 x ( x 1) = 1 x 2 x =1 x 2 x 1= 0 1± 1+ 4 x = 2 = 1 ± 5 2 x > 1

PTSD 17

- - 3 11 3 18 21 3 11 DMAT 72 3 14 PTSD 17 7 24 2 9 2000 2 3 1 5000 2 3 4 14 200 1 2 DMAT DMAT DMAT 3 4 30 70 13 4 5 6 3 4 6 81 DNA DNA DNA 23 1 2 4 2 3 5 25 4 6 10 4 2 4 1 3 2 1 3 1 3 with you forever

MultiWriter 5650C 活用マニュアル

1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 11 1 2 3 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 1 2 3 a b c 30 31 32 C *1 *2 *2 33 2 2 2 2 2 2 2 2 2 34 *1 *2 ± *1 C C 35 36 37 38 39 40 OK 1 2 3 4

2

27 年 度 精 神 保 健 福 祉 基 礎 研 修 会 1 2 350 300 303 323 250 200 150 100 50 218 218 173 136 119 212 204 258 228 247 237 147 142 152 137 137 127 128 134 107 91 86 81 11 14 17 20 3 4 350 300 250 200 150 4.7 3.8

ADVANTAGE_Panf_p14_ ai

,

5 ex. neo^r ex. P. ips induced Pluripotent Stem cells 4 ES ex. ex. DNA

4 MZ DZ MZ DZ ex.mz 0.8 DZ 0.4 2 ex. 0.8 ex. MZ 0.8 DZ 0.6 ex. MZ 0.8 DZ 0.1 E LDL E2 E3 E4 128 152 E2 CC E3 CR E4 RR 10 ex. G6PD CYP CYP P CYP CYP CYP3 CYP CYP 5 ex. neo^r ex. P. ips induced Pluripotent

NHS G.P. CT MRI OECD

NHS G.P. CT MRI OECD WHO WHO CM ,, bio-medical bio-psycho-social bio-psycho-socio-ethicalecological existential WHO physical mental social well-being spiritual spiritual mental heath spiritual health

マニュアル面付け.indd

第138期事業報告書

_PDF.indd

1 加 齢 研 ニュース 58 24 12 1 1. National Institute of Health 3 30 NIH DC 1 20? 58 1 6 8 10 11 13 14 15 12 : 25 6 29 5 : : 2 BMI 25? 1 2 2 70? 1 2 2001 9 11??? 2 3?? 1 500 1? 1,000 61 50 2.! 24 8 19 2 4 108

Microsoft Word - Cai's CV日本語 - May2010.doc

1 130

:010_ :3/24/2005 3:27 PM :05/03/28 14:39

:010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28

2 5 28 4 1 47 2

4 4 5 28 1 2 5 28 4 1 47 2 10 10 22 78 10 28 2 2 10% NHK 30% 32% 3 4 5 1 150 1 5 1 20 2 3 1 2008 2 2 2009 2009 3 3 4 DNA 1 3 2 1 3 3 1 5 3 5 8 18 8 30 5 3 2 60 1 5 2 3 60 2 2 2 60 1 1 5 150 6 3 1 2 150

P15 P211 1 P1 P4 P2 P3 P4 P17

P15 P211 1 P1 P4 P2 P3 P4 P17 P3 P4 P7 P8 P9 2 1 Q A P17 P17 1 2 3 4 3 5 6 7 8 2 P17 Q A P17 4 1 2 3 4 2 P17 P4 P12 P17 P4 5 5 6 7 8 2 P4 P4 6 1 2 3 4 3 P17 P10 P17 7 5 6 7 8 4 0120-096-991 P17 8 1 2 3

障害者職域拡大カリキュラム研究会中間報告書構成案

3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16

q ŁŁ

02

54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148

*p _…u…“…O

*p04-094_ ブログ 09.1.16 :33 PM ページ 4 1600 48 49 a s d f a s d 58 a s a s d 1 a s a s d 90 2009 4 *p04-094_ ブログ 09.1.16 :33 PM ページ 48 20 2004 20081690 5000 2003500 2006 3 40005000 40 48 *p04-094_ ブログ 09.1.16

学習内容と日常生活との関連性の研究－第１部－第３章

25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 366 96 96 66 26 56 57 1 2 58 3 4 5 2004 59 6 70 7 60 9 10 61 366 23 23 15 GPS GPS 62 DNA DNA 63 1 GPS GPS 2004

2 ZERO07 11 4 DNA

1 2 ZERO07 11 4 DNA http://www7a.biglobe.ne.jp/~hakatabay/tvsyoukai353.pdf 3 4 5 5 6 7 8 http://ja.wikipedia.org/wiki/%e5%85%ab%e5%8d%a6 http://ryugen.exblog.jp/12094785 9 10 11 23-1 1-3 3-5 5-7 7-9 9-11

Microsoft Word - 1.抗がん剤治療を受けられるかたへ(最新版).doc

Microsoft Word - 01　実態調査報告書本体

... 4... 5 -... 5 -... 6 -... 7... 8 -... 8 -... 9 -... 10 -... 11 -... 11 -... 12 -... 14 -... 15 -... 15 -... 16 -... 16 -... 17 -... 17 -... 18 -... 18 -... 19 -... 19 -... 20 -... 20 -... 21 -... 22...

-2-

Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-

本文/森枝卓士

フィナレビ106号.indb

2009 3 30 2009 4 14 CDC 2009 4 25 WHO 2009 4 26 2009 4 28 2009 4 28 2009 4 30 2009 5 1 2009 5 8 6 2009 5 9 2009 5 23 2009 6 3 2009 6 9 2500 2009 6 12 WHO 6 2009 6 28 2009 8 9 1 1 2009 8 15 2009 8 19 2010

STOCK 2

.p.t.....id

9784903922386 ISBN978-4-903922-38-6 Contents ?? R RR R R R R R R R R R R R RR R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R r r r R R r r r r Q5 A5 Q10 A10 Q11 A11 Q7 A7 Q8 A8

untitled

Ref. No: KiG14B23-Kokushi22-R01 22 1/23 Ans Ans 1 75 64 74 8 75 75 Ans 9 75.1 2010 Ans Ans 1000 Ans 85cm 90cm 25 130mmHg 85mmHg 100mg/dl HbA1c 5.6 HDL 150mg/dl HDL-C 40mg/dl 1 3 Ans 1 (): 2 (): 3 (): 4

*p175-210_‰³‹ç…e…„…r

*p175-210_ 教 育 テレビ 09.1.16 10:36 PM ページ175 1959 501959 196412 5030 1973 11 15 1950 50 195080 9090 176 177 182 185 12 193 197 205 2009 175 *p175-210_ 教 育 テレビ 09.1.16 10:36 PM ページ176 19593410 50 30 50 1959

~ AM A M Dr. R. L. Jenkins Jenkins Growing up in the Kibbutz Rabin, A. I.

SHINOHARA Mutsuharu : : ~ AM A M Dr. R. L. Jenkins Jenkins Growing up in the Kibbutz Rabin, A. I. Rabin Rabin Shinohara, M. & R. L. Jenkins: MMPI Study of Three Types of Delinquents. J. Clin. Psychol.,,,

世田谷区新型インフルエンザ対策行動計画

ペットブック_表紙＆扉_Fin

ユニセフ表紙_CS6_三.indd

16 179 97 101 94 121 70 36 30,552 1,042 100 700 61 32 110 41 15 16 13 35 13 7 3,173 41 1 4,700 77 97 81 47 25 26 24 40 22 14 39,208 952 25 5,290 71 73 x 99 185 9 3 3 3 8 2 1 79 0 d 1 226 167 175 159 133

Q E Q T a k Q Q Q T Q =

i 415 q q q q Q E Q T a k Q Q Q T Q = 10 30 j 19 25 22 E 23 R 9 i i V 25 60 1 20 1 18 59R1416R30 3018 1211931 30025R 10T1T 425R 11 50 101233 162 633315 22E1011 10T q 26T10T 12 3030 12 12 24 100 1E20 62

2

1 2 3 NEET 4 2 2 5 6 1-2 2005 7 8 CM 9 89 117 1994 1996 36 1997 38 2001 6 28 2005 11 2005.11.22 10 11 12 13 1970 80 2005 explain 14 15 Body Mass Index 16 BMI BMI-1.9 BMI -3.7 16 16 20 18 BMI 22 18.5 BIM

感覚運動段階Ⅵの 言語指導プログラム

1. 2. 3. 4. 5. 6. 12 1218 1824 () (1975) 1. 2. 3. 4. 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. 6. (1996) 5 5 PDS (A) A (1) A (2) (B) IQ31 T C 50 ITP http://www.ed.niigata-u.ac.jp/~nagasawa/

日本のレコード産業１９９９年版

1999 Recording Industry Association of Japan 1999 Recording Industry Association of Japan 1 2 1 2 1 2 5 6 7 8 9 1 11 12 1 1 15 16 17 18 19 2 21 22 2 2 5 5 5 6 6 6 7 8 8 9 1 1 11 12 1 1 1 1 15 1 2 5 6 7

contents

contents 1 4 8 10 12 14 1. 2. 78 79 16 17 18 20 21 21 22 23 23 24 26 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 1. 2. 3. 4. 5. 6. 7. 8. 9. 28 30 30 32 34 35 36 36 45 46 48 52 60 69 70 71 71 72 74 76 76 1. 2. 3.

(2-3)CyberSpace

xy n n n- n n n n n xn n n nn n O n n n n n n n n

表紙_vol9_Summer_再.eps

表紙　vol.5-04

11 20 2 19 8 11 201116 1) 1 2 2) 4 4 20 3) 1 1 4) 25,000 4 25,000 1) 1) 2)

http://www.shijuku.net 11 20 2 19 8 11 201116 1) 1 2 2) 4 4 20 3) 1 1 4) 25,000 4 25,000 1) 1) 2) " " 7,624 20081210 1 ( 20 048-688-6903 W () 90 30 70 190 12 100 10 11 111 10 NPO 180 12 5 10 46 3 46

AD_表紙_FC

AD表紙vol.17.eps

AD表紙vol.17.eps

AD STUDIES Vol.19 2007 37

12331514 20131126 1 2 3 1 2 2 52495 4 1122 1 2 2 2 3 45 1 2 1 3 2 4 Z 8305 1962 8 4 2 1 2 2 35 3 12 1 2 32 4418 4 1 5 323 6 11111 332 5 342 6 1 23 4 2 3 7 3 2 3 25175 19132 8 2 1 1 2 3 4 5 6 7 2 1 2 3

59

58 17 Productivity and CSR BNP 1 2 3 59 60 61 62 1 1 2 3 BMI 4 10 63 5 6 4 7 B BNP 8 1 64 9 2 10 11 1 12 2 65 13 3 14 4 1 15 IT 16 17 66 18 2 19 20 21 67 22 23 IT 40 24 YRP 25 68 26 30 50 27 28 29 MY 69

( ) ー ( () ) 250 200 150 100 50 0 51 20 54 59 33 35 91 92 93 98 99 94 6 7 7 8 9 11 18 17 18 20 22 23 10 9 8 9 9 9 62 40 66 74 41 47 21 22 23 24 25 26 10 8 6 4 2 0 m3/s 7 41.3 5 5 18.4

1

(3) Beck (4) (5) Self- Efficacy (6) (7) (8) (9) (10)

(1) (2) (3) Beck (4) (5) Self- Efficacy (6) (7) (8) (9) (10) cognitive appraisallazarus et al. (11) Lazarus et albandura (12) (13)... (14) (15) (16) Cronbach a.. G-P (17) Generalized Self-Efficacy Sherer

14 12 10 8 6 4 2 0 5 10 15 20 25 30 80 70 60 50 40 30 20 10 0 5 10 15 20 25 30 XX 20 30 40 50 60 70 80 2.3% 2.3% 34.1%3 4.1% 13.6% 13.6% 20 30 40 50 60 70 80 v-scale 6 9 12 15 18 21 24 IQ 55 70 85 100

untitled

1991 92 feminine masculine 1 70 2 86 89 3 009 16 2 3 IQ200 4 1970 5 90 9 90 2 2 Over Time Love Story Over Time Love Story 6 7 2 8 3 3 9 2000 21 21 10 11 1945 12 1949 1974 7 74 SF 5 1992 21 2000 4 1973

clover-375.pdf

8:4511:00 9:0012:30 9:0016:3003-5986-3188 AM PM AM PM AM PM AM PM AM PM AM PM - - - - - - 1 2 3 5 6 7 8:4515:00 9:0016:30 AM PM AM PM AM PM AM PM AM PM AM PM - - - - - - - - - () - - - - - - - 8 10 12

橡scb79h16y08.PDF

S C B 05 06 04 10 29 05 1990 05 0.1 90 05 0.2 06 90 05 06 06 04 04 10 1.9 90 12 2.0 13 10 10 18.0 16.0 6.1 1 10 1.7 10 18.5 0.8 03 04 1 04 42.9 10 20.5 10 4.2 0.7 0.2 0.6 01 00 100 97 11 102.5 04 91.5

untitled

-1- -2- -3- AED -4- 2-5- -6- -7- -8-6-1-28 048-833-1231 2-1-1 048-261-3119 4389-1 048-556-3005 1-13-11 04-2924-1311 2097-1 048-738-3111 1172 04-2953-7111 990-1 048-565-1919 537 048-775-1311 2-2-2 048-924-2111